Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie M Frigault

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Opinion in Pharmacology|September 28, 2014
Is target validation all we need?Melanie M Frigault, J Carl Barrett
Journal of Cellular Physiology|September 27, 2007
Gab2 requires membrane targeting and the Met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the Met receptorMelanie M Frigault, Monica A Naujokas, Morag Park
The Journal of Biological Chemistry|May 27, 2003
Grb2-independent recruitment of Gab1 requires the C-terminal lobe and structural integrity of the Met receptor kinase domainLisa S Lock, Melanie M Frigault, Caroline Saucier, et al.
Journal of Cell Science|March 6, 2009
Live-cell microscopy - tips and toolsMelanie M Frigault, Judith Lacoste, Jody L Swift, et al.
Clinical Chemistry|November 30, 2012
Are companion diagnostics useful?J Carl Barrett, Melanie M Frigault, Simon Hollingsworth, et al.
Journal of Cell Science|March 25, 2010
The Gab1 scaffold regulates RTK-dependent dorsal ruffle formation through the adaptor NckJasmine V Abella, Richard Vaillancourt, Melanie M Frigault, et al.
Journal of Visualized Experiments : Jove|April 5, 2021
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker AnalysisPaola Marco-Casanova, Natalia Lukashchuk, Benedetta Lombardi, et al.
Molecular Biology of the Cell|November 19, 2004
HGF converts ErbB2/Neu epithelial morphogenesis to cell invasionHanane Khoury, Monica A Naujokas, Dongmei Zuo, et al.
Cancer Research Communications|October 26, 2023
Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated TranscriptionMelanie M Frigault, Arushi Mithal, Harvey Wong, et al.
Blood Neoplasia|September 22, 2025
Targeting CDK9 inhibits the growth of KMT2A-rearranged infant leukemia and demonstrates synergy with menin inhibitionRitul Sharma, Chunfen Zhang, Ravi Shah, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Pharmacology|September 28, 2014
Is target validation all we need?Melanie M Frigault, J Carl Barrett
Journal of Cellular Physiology|September 27, 2007
Gab2 requires membrane targeting and the Met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the Met receptorMelanie M Frigault, Monica A Naujokas, Morag Park
The Journal of Biological Chemistry|May 27, 2003
Grb2-independent recruitment of Gab1 requires the C-terminal lobe and structural integrity of the Met receptor kinase domainLisa S Lock, Melanie M Frigault, Caroline Saucier, et al.
Journal of Cell Science|March 6, 2009
Live-cell microscopy - tips and toolsMelanie M Frigault, Judith Lacoste, Jody L Swift, et al.
Clinical Chemistry|November 30, 2012
Are companion diagnostics useful?J Carl Barrett, Melanie M Frigault, Simon Hollingsworth, et al.
Journal of Cell Science|March 25, 2010
The Gab1 scaffold regulates RTK-dependent dorsal ruffle formation through the adaptor NckJasmine V Abella, Richard Vaillancourt, Melanie M Frigault, et al.
Journal of Visualized Experiments : Jove|April 5, 2021
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker AnalysisPaola Marco-Casanova, Natalia Lukashchuk, Benedetta Lombardi, et al.
Molecular Biology of the Cell|November 19, 2004
HGF converts ErbB2/Neu epithelial morphogenesis to cell invasionHanane Khoury, Monica A Naujokas, Dongmei Zuo, et al.
Cancer Research Communications|October 26, 2023
Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated TranscriptionMelanie M Frigault, Arushi Mithal, Harvey Wong, et al.
Blood Neoplasia|September 22, 2025
Targeting CDK9 inhibits the growth of KMT2A-rearranged infant leukemia and demonstrates synergy with menin inhibitionRitul Sharma, Chunfen Zhang, Ravi Shah, et al.
Pageof 4